Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × ixazomib × Clear all

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms